Articles | EuroIntervention

• Aug 20, 2008

Health economics: drug-eluting stents – are they worth the money?

Gershlick A, Fearn S

free

• May 13, 2008

Today Europe, tomorrow the world!

Serruys PW

free

• May 13, 2008

Percutaneous Cardiovascular Intervention. The time has come for a big change...

Wijns W

free

• May 13, 2008

Chronic total coronary occlusions and the Occluded Artery Trial. A critical appraisal.

Werner G, Di Mario C, Galassi A, Gershlick A, Reimers B, Sianos G, Sievert H, Lefèvre T, Reifart N

free

• May 13, 2008

Last nail in the coffin of late lumen loss?

Biondi-Zoccai G, Agostoni P, Sheiban I

free

• May 13, 2008

Together we achieve more...

Wijns W, Marco J, Doncieux M

free

• May 13, 2008

Why don't we return to bare metal stents?

Hess O, Karjalainen P, Wallentin S, de Winter R

free

• May 13, 2008

Why we should never return to bare metal stents?

Morice M, Thomas M, Buellesfeld L, Grube E, Colombo A

free

• May 13, 2008

Cardiovascular repair and regeneration 2008: the Fourth International Conference on Cell Therapy for Cardiovascular Disease (IC3D)

Sherman W, Dimmeler S, Hare J, Penn M

free

• May 13, 2008

Highlights from ICI-Innovations in Cardiovascular Interventions. December 3-5, 2007, Tel Aviv, Israel

Beyar R, Lotan C

free

• May 13, 2008

EXCELLA™ First-in-Man (FIM) study: safety and efficacy of novolimus-eluting stent in de novo coronary lesions

Costa Júnior J, Abizaid A, Feres F, Costa R, Seixas A, Maia F, Abizaid An, Tanajura L, Staico R, Siqueira D, Meredith L, Bhat V, Yan J, Ormiston J, Sousa A, Fitzgerald P, Sousa J

free

• May 13, 2008

Biodegradable-polymer-based, sirolimus-eluting Supralimus® stent: 6-month angiographic and 30-month clinical follow-up results from the Series I prospective study

Dani S, Kukreja N, Parikh P, Joshi H, Prajapati J, Jain S, Thanvi S, Shah B, Dutta J-P

free

• May 13, 2008

Two year follow-up after primary PCI with a paclitaxel-eluting stent versus a bare-metal stent for acute ST-elevation myocardial infarction (the PASSION trial): a follow-up study

Dirksen M, Vink M, Suttorp MJ, Thijssen J, Patterson M, Slagboom T, Kiemeneij F, Laarman GJ

free

• May 13, 2008

Novel drug eluting stent system for customised treatment of coronary lesions: CUSTOM I feasibility trial 24 month results

Grube E, Sievert H, Hauptmann K-E, Mueller R, Gerckens U, Buellesfeld L, Ako J, Shimohama T, Costa M, Fitzgerald P

free

• May 13, 2008

Diabetic patients treated for unprotected left main coronary artery disease with drug eluting stents: a 3-year clinical outcome study. The Diabetes and Drug Eluting stent for LeFT main registry (D-DELFT)

Meliga E, Garcia-Garcia H, Valgimigli M, Chieffo A, Biondi-Zoccai G, O’ Maree A, Gonzalo N, Cook S, Cruz-González I, Marra S, De Servi S, Palacios I, Windecker S, van Domburg R, Colombo A, Sheiban I, Serruys PW

free